Organic dust induced pulmonary disease - the role of mould derived beta-glucan

Ragnar Rylander1

  • 1BioFact Environmental Research Center, Bjorkasv 21, Lerum, Sweden. envhealth@biofact.se

Insights

Mould

Area of Science:

  • Immunology
  • Environmental Health
  • Pulmonary Medicine

Background:

  • Beta-glucans are components of mould cell walls.
  • Environmental exposure to moulds can lead to pulmonary diseases.
  • The immune response to inhaled beta-glucans is not fully understood.

Purpose of the Study:

  • To evaluate the role of beta-glucan in environmentally related pulmonary disease.
  • To analyze the effects of beta-glucan on the immune system at the cellular level.

Main Methods:

  • Systematic review of published articles.
  • Analysis of studies involving airway administration of beta-glucan (intratracheal injection or inhalation).
  • Examination of data on immune cell aggregation and inflammatory cytokine production.

Main Results:

  • High doses of beta-glucan induce inflammatory responses (cytokine activation, neutrophil invasion).
  • Lower doses influence antigen response and Th2-driven immune responses (e.g., eosinophils).
  • Beta-glucan can induce both Th1 and Th2 immune responses.

Conclusions:

  • Beta-glucan exposure may contribute to conditions like atopy/allergy, hypersensitivity pneumonitis, and toxic pneumonitis.
  • Measuring beta-glucan levels in the environment is crucial for risk assessment and prevention.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Biodeterioration01:28

Biodeterioration

Biodeterioration refers to the unwanted alteration of materials caused by microorganisms—especially fungi—which damage both organic substrates (paper, wood, textiles) and inorganic ones (stone, plaster, glass). Unlike abiotic decay, biodeterioration results from biological activity that produces physical disruption and chemical degradation.Physical deterioration occurs as fungal hyphae penetrate pores, cracks, and surface irregularities. Hyphal turgor pressure, thigmotropic growth along...